Searched for
CELOGEN
Dr Reddy’s heading for big trouble: Amit Rajan, Celogen Life SciencesThere are multiple problems ahead of Dr Reddy’s in coming days, says Rajan.- Beaten-down pharma stocks hope for boost from new USFDA chiefScott Gottlieb is known to favour quicker entry of generic drugs in the market.
- The new USFDA commissioner actually knows his job: Amit Rajan, Director, Celogen Life SciencesData integrity per se will not be an issue for big Indian pharma companies: Amit Rajan, Director, Celogen Life Sciences.
- Divi's Lab gets US FDA import alert for Visakhapatnam unit: Amit Rajan, Celogen Life ScienceDivi's as we all had the impression that it is bluest of the blue chip but I always based on the observations thought that they qualify for...
- The jewel of the Indian pharma crown has lost its shine: Amit Ranjan on Sun PharmaSun Pharma got two inspections – one for Mohali and one for Halol sight – and if you summarise, I am sorry to say that the jewel of the Ind...
- Sun Pharma will be unstoppable if it integrates Ranbaxy well: Amit Rajan, Director, Celogen Life Science"If Ranbaxy would have continued, it would have become the best brand in India," says Amit Rajan, Director, Celogen Life Science.
- Natco will out-license molecules to big pharma: Amit Rajan, Director, Celogen LifeAmit Rajan, Director, Celogen Life says that Micro Labs will quickly come out of the FDA and midcap space as they have a good R&D pipeline.
Load More